Catalyst Wire Dossier Catalyst Wire Dossier

AMONDYS 45

Casimersen · Sarepta Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for AMONDYS 45, covering 2021-02-25 to 2026-01-06. Get the full timeline:

Most recent: FDA Approved: AMONDYS 45 — Supplemental Application (Sarepta Therapeutics, Inc.)

See pricing